Product Reports Resources Pricing Login Book a demo

Curebase

Health Tech & Medtech · San Francisco, United States · Founded 2017

Curebase operates in the clinical trials industry, providing innovative software solutions designed to enhance patient engagement and data accuracy. The company serves pharmaceutical companies, medical device manufacturers, and contract research organizations (CROs) by offering a suite of tools including ePRO (electronic Patient-Reported Outcomes), eCOA (electronic Clinical Outcome Assessments), eConsent, and EDC (Electronic Data Capture). These tools are highly configurable, allowing for rapid study launches and optimized participant experiences. Curebase's business model revolves around licensing its software to clients, who use it to streamline their clinical trials, improve data quality, and ensure regulatory compliance. Revenue is generated through subscription fees and service contracts. The company operates in a competitive market but differentiates itself with its focus on user-friendly design and robust data collection capabilities. Keywords: clinical trials, ePRO, eCOA, eConsent, EDC, patient engagement, data accuracy, pharmaceutical, medical devices, CROs.

Valuation $100–500M
Revenue $10–50M
Headcount <100
Total funding $50–100M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Curebase and the history behind them.

Investors

17 investors on Curebase's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Series A 9 investors entered at this stage
Xfund
Notable Capital
Bold Capital Partners
Industry Ventures
Gaingels
World Innovation Lab
ACrew Capital
Gilead Sciences
Positive Sum
Series B+ 7 investors entered at this stage
Gaingels
Positive Sum
Industry Ventures
Pioneer Fund
Gilead Sciences
World Innovation Lab
ACrew Capital

Global footprint

Where Curebase has talent and traffic

Workforce by country
9 countries with
team presence
🇺🇸 United States57.1%
🇧🇷 Brazil11.9%
🇳🇮 Nicaragua9.5%
🇨🇦 Canada7.1%
🇬🇹 Guatemala2.4%
Top 5 of 9 shown
Web traffic by country
6.9K monthly visits
across markets
🇺🇸 United States50.7%
🇬🇧 United Kingdom18.8%
🇮🇳 India14.5%
🇵🇹 Portugal11.6%
🇨🇦 Canada2.9%
Top 5 markets shown

Talent graph

The shape of Curebase's talent

Dealroom maps Curebase's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

10 team members profilednamed & role-tagged by Dealroom
56 employeestotal headcount
3 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Curebase's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Curebase

An AI-synthesized read of the highest-engagement posts about Curebase on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Curebase on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.